Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 329

1.

MeCP2 and Rett syndrome: reversibility and potential avenues for therapy.

Gadalla KK, Bailey ME, Cobb SR.

Biochem J. 2011 Oct 1;439(1):1-14. doi: 10.1042/BJ20110648. Review.

PMID:
21916843
2.

Reversibility of functional deficits in experimental models of Rett syndrome.

Cobb S, Guy J, Bird A.

Biochem Soc Trans. 2010 Apr;38(2):498-506. doi: 10.1042/BST0380498. Review.

PMID:
20298210
3.

Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice.

Chen RZ, Akbarian S, Tudor M, Jaenisch R.

Nat Genet. 2001 Mar;27(3):327-31.

PMID:
11242118
4.

MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution.

Kaufmann WE, Johnston MV, Blue ME.

Brain Dev. 2005 Nov;27 Suppl 1:S77-S87. Epub 2005 Sep 22. Review.

PMID:
16182491
5.

MeCP2 dysfunction in Rett syndrome and related disorders.

Moretti P, Zoghbi HY.

Curr Opin Genet Dev. 2006 Jun;16(3):276-81. Epub 2006 May 2. Review.

PMID:
16647848
6.

The story of Rett syndrome: from clinic to neurobiology.

Chahrour M, Zoghbi HY.

Neuron. 2007 Nov 8;56(3):422-37. Review.

8.

The molecular pathology of Rett syndrome: synopsis and update.

Akbarian S, Jiang Y, Laforet G.

Neuromolecular Med. 2006;8(4):485-94. Review.

PMID:
17028371
9.

Methyl CpG-binding protein 2 (a mutation of which causes Rett syndrome) directly regulates insulin-like growth factor binding protein 3 in mouse and human brains.

Itoh M, Ide S, Takashima S, Kudo S, Nomura Y, Segawa M, Kubota T, Mori H, Tanaka S, Horie H, Tanabe Y, Goto Y.

J Neuropathol Exp Neurol. 2007 Feb;66(2):117-23.

10.

Partial rescue of MeCP2 deficiency by postnatal activation of MeCP2.

Giacometti E, Luikenhuis S, Beard C, Jaenisch R.

Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1931-6. Epub 2007 Jan 31.

11.

MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy.

Rastegar M, Hotta A, Pasceri P, Makarem M, Cheung AY, Elliott S, Park KJ, Adachi M, Jones FS, Clarke ID, Dirks P, Ellis J.

PLoS One. 2009 Aug 27;4(8):e6810. doi: 10.1371/journal.pone.0006810.

12.

MeCP2 binds to non-CG methylated DNA as neurons mature, influencing transcription and the timing of onset for Rett syndrome.

Chen L, Chen K, Lavery LA, Baker SA, Shaw CA, Li W, Zoghbi HY.

Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5509-14. doi: 10.1073/pnas.1505909112. Epub 2015 Apr 13. Erratum in: Proc Natl Acad Sci U S A. 2015 Jun 2;112(22):E2982.

13.

The neurobiology of Rett syndrome.

Akbarian S.

Neuroscientist. 2003 Feb;9(1):57-63. Review.

PMID:
12580340
14.

MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain.

Nguyen MV, Du F, Felice CA, Shan X, Nigam A, Mandel G, Robinson JK, Ballas N.

J Neurosci. 2012 Jul 18;32(29):10021-34. doi: 10.1523/JNEUROSCI.1316-12.2012.

15.

Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.

Alvarez-Saavedra M, Sáez MA, Kang D, Zoghbi HY, Young JI.

Hum Mol Genet. 2007 Oct 1;16(19):2315-25. Epub 2007 Jul 17.

16.

Postnatal loss of methyl-CpG binding protein 2 in the forebrain is sufficient to mediate behavioral aspects of Rett syndrome in mice.

Gemelli T, Berton O, Nelson ED, Perrotti LI, Jaenisch R, Monteggia LM.

Biol Psychiatry. 2006 Mar 1;59(5):468-76. Epub 2005 Sep 30.

PMID:
16199017
17.

The relationship of Rett syndrome and MECP2 disorders to autism.

Neul JL.

Dialogues Clin Neurosci. 2012 Sep;14(3):253-62. Review.

18.

Abnormalities of cell packing density and dendritic complexity in the MeCP2 A140V mouse model of Rett syndrome/X-linked mental retardation.

Jentarra GM, Olfers SL, Rice SG, Srivastava N, Homanics GE, Blue M, Naidu S, Narayanan V.

BMC Neurosci. 2010 Feb 17;11:19. doi: 10.1186/1471-2202-11-19.

19.

Rett syndrome: methyl-CpG-binding protein 2 mutations and phenotype-genotype correlations.

Amir RE, Zoghbi HY.

Am J Med Genet. 2000 Summer;97(2):147-52. Review.

PMID:
11180222
20.

The impact of MECP2 mutations in the expression patterns of Rett syndrome patients.

Ballestar E, Ropero S, Alaminos M, Armstrong J, Setien F, Agrelo R, Fraga MF, Herranz M, Avila S, Pineda M, Monros E, Esteller M.

Hum Genet. 2005 Jan;116(1-2):91-104. Epub 2004 Nov 11.

PMID:
15549394
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk